-
What 5-EdU Can—and Cannot—Show in Glioblastoma
2026-10-15
The 2025 glioblastoma study used 5-Ethynyl-2'-deoxyuridine (5-EdU) as one readout of DNA synthesis while investigating hypoxia-associated S100A10 signaling and temozolomide resistance. Its results support an association between S100A10, proliferative behavior, glycolytic markers, apoptosis, and PI3K-AKT signaling in cultured glioblastoma models, but 5-EdU incorporation alone cannot establish completed cell division, tumor growth, or clinical drug resistance.
-
Anti-NFH Antibody: Evidence and Scope
2026-10-15
The Anti-Neurofilament Heavy Polypeptide Rabbit Monoclonal Antibody (MA3954) is documented by APExBIO as an unconjugated rabbit monoclonal antibody directed against a peptide derived from human NEFH, with supplier-listed applications in Western blotting and paraffin-embedded immunohistochemistry. In the absence of an identity-matched research paper, the product record supports a conceptual role in NEFH immunodetection but does not establish assay performance, quantitative validity, or direct evidence for neuronal or axonal pathology.
-
L-Phenylephrine: Mechanism and Evidence Scope
2026-10-14
APExBIO’s product documentation identifies L-Phenylephrine as an adrenergic α1A receptor agonist and describes cardiovascular, neural, cutaneous, and nasal-airway findings. These claims provide a mechanistic and measurement framework, but the available documentation does not supply identity-matched papers, sample sizes, effect estimates, or sufficient methodological detail for independent assessment.
-
Radiotherapy, Checkpoint Blockade, and Roscovitine
2026-10-14
A 2025 Cancer Letters study reports that radiotherapy combined with PD-1 and TIGIT blockade improved local and distant tumor control and generated CD8+ T-cell–associated immune memory in several mouse models. The findings support a preclinical mechanism, but they do not establish clinical efficacy or demonstrate a role for Roscovitine (Seliciclib) in that therapeutic combination.
-
Phenylephrine in Sex-Divergent Hypertension Research
2026-10-13
A mouse study found that chronic angiotensin II produced a substantially larger blood-pressure increase in males than females, with gonadectomy altering both responses. Phenylephrine served as a baroreflex probe in that study; it did not test L-Phenylephrine as a treatment or establish the compound’s broader supplier-described cardiovascular and neural effects.
-
L-Phenylephrine: Sex-Specific Hypertension Evidence
2026-10-13
A mouse study found that chronic angiotensin II produced a substantially larger blood-pressure increase in males than females, with hormone-dependent differences in baroreflex and autonomic responses. These findings provide context for adrenergic research but do not establish that APExBIO’s L-Phenylephrine product caused, prevented, or mechanistically explains the reported hypertension phenotype.
-
IDH2, α-KG and HIF-1α in Colorectal Cancer
2026-10-12
A preclinical study links elevated IDH2 with colorectal cancer progression through altered α-ketoglutarate metabolism, mitochondrial energy production and HIF-1α signaling. The findings support a metabolic model, but the evidence remains limited to cellular and animal systems and does not establish a clinical treatment strategy or show that Octyl-α-ketoglutarate was used in the study.
-
Sex, Angiotensin II, and Mouse Hypertension
2026-10-12
Xue, Pamidimukkala, and Hay examined whether male and female mice differ in chronic angiotensin II–induced hypertension and whether gonadal status, baroreflex control, and sympathetic activity help explain that difference. The study reports a substantially larger blood-pressure increase in males, while its mechanistic conclusions remain bounded by the mouse model and broad hormonal and autonomic interventions.
-
Hematoxylin and Eosin Kit: Evidence Scope
2026-10-11
A source-limited overview of APExBIO K1142, covering its documented identity, stated purpose in H&E staining, and the absence of product-specific evidence for performance or clinical use.
-
Gamithromycin PK/PD in a Murine Lung Model
2026-10-10
Yang et al. linked unbound gamithromycin exposure with antibacterial effects in a neutropenic mouse lung infection model of Pasteurella multocida. The study identified fAUC0–24/MIC as the most informative exposure–response index, while also showing why its numerical targets should be interpreted as model-specific evidence rather than direct clinical dosing recommendations.
-
CAPE Against C. difficile: Toxin and Microbiota Insights
2026-10-10
Guo and colleagues identify caffeic acid phenethyl ester (CAPE) as a candidate inhibitor of the C. difficile toxin TcdB and connect its activity with changes in gut microbiota and metabolites. The study supports an anti-virulence research strategy, but its moderate murine effects, mechanistic uncertainties around direct toxin binding, and lack of human evidence limit immediate clinical interpretation.
-
Ferroelectric–Liquid Metal Photoreceptors Explained
2026-10-09
Zhang and colleagues report a ferroelectric–liquid metal hybrid artificial photoreceptor that combines broad-spectrum photoresponsiveness with biomimetic visual adaptation. In rodent retinal-degeneration models, the implant generated photovoltage above 200 mV, supported visible and infrared light responses, and showed stable integration over three months, while remaining a preclinical proof of concept.
-
From Surface Labels to Proteostasis Insight
2026-10-09
A thought-leadership perspective on using Sulfo-NHS-SS-Biotin to connect cell-surface receptor biology with proteostasis research, informed by recent GABRA1 frameshift findings and framed by translational evidence limits.
-
Silver Nanoparticles, Ferroptosis, and Liver Inflammation
2026-10-08
Zheng et al. connect silver nanoparticle exposure with ferroptosis-related liver inflammation by integrating public gene-expression datasets with validation in adult zebrafish. The study highlights Arrdc3, Txnip, and Egfr as candidate ferroptosis-associated genes and links the response to iron accumulation, lipid peroxidation, mitochondrial abnormalities, glucose metabolism, and insulin signaling.
-
Cyclic di-GMP: From Biofilm Signal to Translation
2026-10-08
A source-grounded perspective on cyclic di-GMP as an intracellular second messenger, small-molecule antitoxin, and STING-linked research tool. The article connects biofilm persistence biology with immune modulation research while distinguishing reported evidence from translational hypothesis.